Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec 28:13:1120281.
doi: 10.3389/fimmu.2022.1120281. eCollection 2022.

Editorial: JAK inhibition in autoimmune and inflammatory diseases

Jean-Baptiste Telliez  1 , Massimo Gadina  2 , Kamran Ghoreschi  3 , Olli Silvennoinen  4 , Francesca Romana Spinelli  5
Affiliations
Editorial

Editorial: JAK inhibition in autoimmune and inflammatory diseases

Jean-Baptiste Telliez et al. Front Immunol. .
No abstract available

Keywords: JAK; JAK - STAT signaling pathway; STAT (signal transducer and activator of transcription); autoimmune diseases; inflammatory disease.

PubMed Disclaimer

Conflict of interest statement

J-BT is an employee of Pfizer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic JAK inhibition in autoimmune and inflammatory diseases

References

    1. Stark GR, Darnell JE, Jr. The JAK-STAT pathway at twenty. Immunity (2012) 36(4):503–14. doi: 10.1016/j.immuni.2012.03.013 - DOI - PMC - PubMed
    1. Schwartz DM, Bonelli M, Gadina M, O'Shea JJ. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol (2016) 12(1):25–36. doi: 10.1038/nrrheum.2015.167 - DOI - PMC - PubMed
    1. Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O'Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discovery (2017) 17(1):78. doi: 10.1038/nrd.2017.267 - DOI - PMC - PubMed
    1. Spinelli FR, Colbert RA, Gadina M. JAK1: Number one in the family; number one in inflammation? Rheumatol (Oxford) (2021) 60(Suppl 2):ii3–ii10. doi: 10.1093/rheumatology/keab024 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources